CATALYST PHARMACEUTICALS, INC. (CPRX) — Analysis Summary
CATALYST PHARMACEUTICALS, INC. (CPRX) has a market cap of $0.00M with year-over-year revenue growth of +19.8%. Net margin stands at 36.4%. The stock trades at a P/E ratio of 0.0.
Key Takeaways
- Revenue changed +19.8% year-over-year
- Net margin of 36.4%
- P/E ratio of 0.0
Compared with its sector, CPRX posted revenue growth of +19.8% and trades at a P/E of 0.0.
CATALYST PHARMACEUTICALS, INC. (CPRX)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.